CMS finally announces interim reimbursement rates for some molecular diagnostic tests but pricing uncertainty remains

CMS published a long-awaited list of interim prices for new molecular diagnostic codes. This list is a key step in the process of changing the way molecular diagnostics are reimbursed.

Read more: CMS finally announces interim reimbursement rates for some molecular diagnostic tests but pricing uncertainty remains


Download PDF Share Back To Listing
Loading data